What is driving interest in Maze Therapeutics right now? Maze Therapeutics (MAZE) has drawn fresh attention after recent trading, with the stock closing at $46.01 and showing mixed short term moves, ...

After Maze Therapeutics opted not to participate in the National Advertising Division’s (NAD’s) self-regulatory process for monitoring promotional claims, a case brought by competitor Vertex ...

Fierce 15 winner Maze Therapeutics just added $190 million to its fundraising pile in time to help its lead candidate, MZE001, make a clinical debut. Maze wrapped up the fundraising round on Monday.

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...

Can you survive navigating a maze at high speeds and then beatung your previous score? Ship v Maze will be coming out this ...

As if the Upside Down wasn't a terrifying maze in itself, someone has created one in our world. A colossal maze inspired by Netflix favorite Stranger Things has been unveiled in Lafayette, Indiana, ...